Condition
Retinopathy of Prematurity (ROP) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Retinopathy of Prematurity (ROP) clinical trials that are recruiting, at sites in 4 countries (most in United States (3), Turkey (Türkiye) (1), China (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Retinopathy of Prematurity (ROP) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Imaging retinal structure in premature babies to guide care | — | Durham, North Carolina and 1 other locations | Recruiting | Jul 31, 2026 |
| Does early red blood cell transfusion affect complications and neurodevelopment in premature infants? | — | Rijeka, Primorje-Gorski Kotar County | Recruiting | Aug 14, 2025 |
| Testing FLQ-101 for retinopathy of prematurity in very premature newborns | Phase 1 | Austin, Texas | Recruiting | Jul 30, 2025 |
| Low-dose Conbercept treatment for Retinopathy of Prematurity | — | Xi'an, Shaanxi and 2 other locations | Recruiting | Dec 5, 2024 |
| Evaluating pain relief methods during eye exams for premature infants | — | Izmir, Menemen | Recruiting | Nov 19, 2024 |
| New imaging technology for diagnosing retinopathy of prematurity in infants | — | Nashville, Tennessee | Recruiting | Sep 25, 2024 |
All recruiting trials (6)
-
Imaging retinal structure in premature babies to guide care
This study tests whether bedside ultra-widefield eye imaging can better guide treatment decisions for retinopathy of prematurity in preterm infants.
-
Does early red blood cell transfusion affect complications and neurodevelopment in premature infants?
This study tests whether giving blood transfusions in the first month of life in premature babies is linked to early complications like ROP, NEC, BPD, IVH, and to later neurodevelopmental outcomes.
-
Testing FLQ-101 for retinopathy of prematurity in very premature newborns
This will test whether giving FLQ-101 to very premature babies (born at 26+0 to 27+6 weeks and weighing ≥650 g) is safe and produces the expected drug effects in their bodies.
-
Low-dose Conbercept treatment for Retinopathy of Prematurity
This study is testing if a low-dose eye treatment called Conbercept can help preterm infants with Retinopathy of Prematurity feel better and improve their vision.
-
Evaluating pain relief methods during eye exams for premature infants
This study is testing two different ways to hold premature infants during eye exams to see which one helps reduce their pain better.
-
New imaging technology for diagnosing retinopathy of prematurity in infants
This study is testing a new imaging technology to help doctors better see and understand eye problems in premature infants with retinopathy of prematurity.
Related topics
Quick answers
How many Retinopathy of Prematurity (ROP) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), Turkey (Türkiye) (1 trial), China (1 trial), Croatia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.